Retour sur lavenir.net
   PROXIMUS 6.185 € (-0,08 %)     FAGRON 21.000 € (-0,47 %)     ONWARD MEDICAL 2.740 € (+2,81 %)     NYXOAH 1.358 € (+3,66 %)     KINEPOLIS GROUP 48.350 € (-0,51 %)     KBC ANCORA 94.200 € (+1,29 %)     ACKERMANS V.HAAREN 272.000 € (+1,42 %)     DEME GROUP 181.600 € (-0,33 %)     LOTUS BAKERIES 11 900.000 € (-3,25 %)     ARGENX SE 853.800 € (-0,23 %)     AB INBEV 67.180 € (+0,06 %)     SYENSQO 80.400 € (-0,43 %)     SOFINA 255.000 € (-0,62 %)     EXMAR 12.000 € (+0,42 %)     MONTEA 63.500 € (+0,16 %)     AGEAS 75.100 € (+1,56 %)     DECEUNINCK 2.435 € (+0,62 %)     FLUXYS BELGIUM D 22.400 € (0,00 %)     ELIA GROUP 117.000 € (-0,51 %)     D'IETEREN GROUP 170.300 € (+1,73 %)     NYRSTAR 0.056 € (-10,79 %)     RECTICEL 12.900 € (+1,42 %)     AZELIS GROUP 12.110 € (-0,49 %)     CARE PROPERTY INV. 12.180 € (-0,81 %)     ECONOCOM GROUP 1.470 € (-1,67 %)     TESSENDERLO 21.200 € (-2,75 %)     AGFA-GEVAERT 0.402 € (-0,37 %)     VGP 71.400 € (-0,28 %)     CMB.TECH 16.700 € (+0,48 %)     TINC 11.020 € (0,00 %)     HOME INVEST BE. 18.080 € (-0,44 %)     TUBIZE-FIN 175.600 € (+0,34 %)     HYLORIS 4.250 € (-0,23 %)     XIOR 25.300 € (-0,78 %)     RETAIL ESTATES 63.600 € (-1,85 %)     ONTEX GROUP 2.185 € (-1,58 %)     EVS 28.250 € (-0,35 %)     VAN DE VELDE 29.900 € (-0,66 %)     TITAN S.A. 51.100 € (-0,58 %)     BARCO 7.470 € (-0,47 %)     AEDIFICA 65.700 € (-0,15 %)     BREDERODE 105.800 € (+1,93 %)     UCB 205.600 € (+1,93 %)     WDP 20.980 € (+0,58 %)     IBA 15.100 € (-0,92 %)     VIOHALCO 16.400 € (-1,20 %)     ACCENTIS 0.027 € (-1,85 %)     NEXTENSA 46.485 € (-0,03 %)     SOLVAC NOM(RETAIL) 82.500 € (+0,61 %)     JENSEN-GROUP 74.600 € (+2,75 %)     VASTNED 28.250 € (+0,36 %)     CAMPINE 187.000 € (-1,58 %)     COLRUYT 38.060 € (-0,21 %)     INCLUSIO SA/NV 16.350 € (-0,91 %)     SHURGARD 22.600 € (+1,35 %)     SIPEF 105.200 € (-1,13 %)     GIMV 45.500 € (+2,25 %)     CENERGY 23.360 € (+2,37 %)     BPOST 1.220 € (-1,61 %)     IMMOBEL 19.900 € (-1,97 %)  
   ALPES (COMPAGNIE) 18.740 € (-1,26 %)     LAGARDERE SA 17.960 € (-1,32 %)     LARGO 1.210 € (-0,82 %)     ABIONYX PHARMA 1.840 € (+1,77 %)     AEGON 7.898 € (+1,02 %)     ALSTOM 15.875 € (+2,42 %)     ADYEN 928.700 € (+1,06 %)     FASTNED 39.700 € (-1,98 %)     ECOSLOPS 1.100 € (-9,84 %)     SANOFI 73.260 € (-0,42 %)     DANONE 61.380 € (-0,62 %)     LVMH 415.300 € (+2,16 %)     OVH 14.910 € (+2,05 %)     COMPAGNIE ODET 1 288.000 € (+0,31 %)     ADP 108.900 € (+0,55 %)     GTT 216.200 € (+1,03 %)     BNP PARIBAS ACT.A 103.760 € (+1,09 %)     TOTALENERGIES 78.770 € (+0,50 %)     CROSSJECT 1.380 € (-0,58 %)     APERAM 44.940 € (-0,71 %)     AIRBUS 199.400 € (+1,85 %)     AIR FRANCE -KLM 11.635 € (+0,43 %)     ING GROEP N.V. 32.090 € (+1,44 %)     CREDIT AGRICOLE 18.625 € (+0,46 %)     SCHNEIDER ELECTRIC 291.100 € (+1,29 %)     UBISOFT ENTERTAIN 5.220 € (+7,08 %)     VALLOUREC 18.535 € (-0,46 %)     RENAULT 29.580 € (+2,28 %)     EXOSENS 54.800 € (-2,06 %)     THERMADOR GROUPE 71.300 € (-0,56 %)     ACCOR 46.070 € (+0,59 %)     DBT 0.082 € (+36,67 %)     ABN AMRO BANK N.V. 43.520 € (+2,06 %)     BIOMERIEUX 70.400 € (-1,68 %)     STELLANTIS NV 4.678 € (+3,10 %)     VALEO 14.815 € (+0,07 %)     KENDRION 18.900 € (-0,32 %)     GETLINK SE 18.450 € (0,00 %)     MON COURTIER ENERG 5.600 € (-3,45 %)     GENFIT 13.020 € (-4,96 %)     BE SEMICONDUCTOR 189.250 € (+2,80 %)     BOUYGUES 43.980 € (+0,30 %)     SHELL PLC 41.415 € (+0,45 %)     ASML HOLDING 1 478.400 € (+0,28 %)     CVC CAPITAL 13.660 € (+0,07 %)     BAM GROEP KON 11.350 € (+2,07 %)     VOLTALIA 5.000 € (+3,52 %)     RISING STONE 43.500 € (-2,14 %)     ADVICENNE 0.866 € (-1,93 %)     2CRSI 28.820 € (-4,95 %)     COVIVIO 47.680 € (-0,29 %)     GUILLEMOT 4.110 € (-2,61 %)     VEOLIA ENVIRON. 31.440 € (0,00 %)     FLOW TRADERS 28.740 € (+0,91 %)     NN GROUP 78.260 € (+1,93 %)     KERING 238.600 € (+1,90 %)     NANOBIOTIX 31.300 € (+0,06 %)     VINCI 111.450 € (+0,81 %)     DSM FIRMENICH AG 88.920 € (-1,18 %)     CAPITAL B 5.160 € (+0,66 %)  
News Réglementées
01/07/2026 18:29

Aperam Update on Q2 2026 market & financial trends

Aperam S.A. / Mot-clé(s) : Autres
Aperam Update on Q2 2026 market & financial trends

01-Juil-2026 / 18:29 CET/CEST


 Aperam Update on Q2 2026 market & financial trends

 

Luxembourg, 1 July 2026 (18:30 CEST) - Aperam issues the following update before entering its quiet period ahead of the upcoming Q2 2026 quarterly results announcement on 30 July 2026 to remind market participants of the standing guidance, earnings drivers and events that should be considered.

 

Q2 2026 outlook

Aperam confirms the Q2 2026 outlook, as specified in the Q1 2026 presentation, the management podcast and the conference call on 30 April 2026:

  • Adjusted EBITDA in Q2 2026 is expected significantly higher than in Q1 (EUR 90m).
  • Q2 marks the period where Brazil returns with its full seasonal strength.
  • Trade defense is already having an impact in Q2: Europe has experienced relief from lower import volumes, directly correlating to higher capacity utilization in the European mills.
  • Valuation gains are expected as guided due to timing from prior period.
  • Net financial Debt expected to be slightly lower than Q1 - deleveraging on track thanks to continued capital efficiency over the last 6 quarters.

The Aperam-compiled consensus for Q2 2026 adjusted EBITDA stands at EUR 121m (average).

Consensus is updated and published at: https://www.aperam.com/investors/news-contacts/results

 

Current trading

  • European climate: Aperam guidance on low European demand unchanged since 3 quarters, underlying competitiveness of the company basis for our confidence in Q2 guidance. While the European business climate remains challenging, the recent increase in capacity utilization is driven solely by lower import volumes thanks to structural trade defense strengthening in Europe.
  • Regional trends: Europe is running into its summer vacation season while Brazil continues into another seasonally strong quarter.
  • Alloys & Specialities continues its upward trajectory, supported by a healthy order book in LNG, electrical & electronics and steady aerospace demand.
  • Regulatory Frameworks: CBAM commenced at the beginning of 2026, with its positive effects expected to ramp up over the next few years. Trade defense measures in Europe officially took effect on 1 July 2026, with positive effects already visible in the first half of the year as previously communicated. Aperam expects these positive impacts to continue throughout the remainder of 2026.

 

Other points

  • Leadership Journey Phase 6 was launched at the beginning of 2026, focusing on value growth by leveraging our integrated value chain and innovation with expected gains of EUR 150m from 2026 to 2028. Q1 2026 has already delivered a contribution of EUR 18m, with further gains expected to materialize in Q2 2026.
     

Please note that forward guidance for adjusted EBITDA, cash flow and net debt is always provided on stable commodity price assumptions. Accordingly, these projections do not account for potential impacts from ongoing fluctuations in energy prices.

 

Commodity prices & FX

monthly average

 

MAR 26

APR 26

MAY 26

JUN 26

Nickel LME

USD/t

16,916

19,284

18,867

16,088

Ferrochrome

USD/t

2,479

2,456

2,439

2,372

EU Stainless Scrap

USD/t

1,448

1,624

1,605

1,558

EU Stainless CR 2mm 304

USD/t

2,856

3,037

3,064

2,956

USD/EUR

x

1.16

1.17

1.17

1.14

USD/BRL
Source: Bloomberg, LME, CRU

x

5.18

4.96

5.04

5.16

 

The Q2 2026 financial performance will be published before the market opens on Thursday, 30 July 2026.

 

Aperam management will host a conference call for members of the investment community to discuss the
Q2 2026 financial performance on 30 July 2026 at 14:00 CEST.

 

Financial Calendar

 

Earnings

 

Thursday, 30 July 2026       Q2/H1 2026 results

Friday, 6 November 2026        Q3/9M 2026 results

 

 

 

Capital Markets Day

 

Wednesday, 18 November 2026 Paris

 

 

Forward Looking Statements

This document may contain forward-looking information and statements about Aperam SA and its subsidiaries. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Forward-looking statements may be identified by the words ‘’believe’’, ‘’expect’’, ‘’anticipate’’, ‘’target’’ or similar expressions. Although Aperam’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors and holders of Aperam’s securities are cautioned that forward-looking information and statements are subject to numerous risks and uncertainties, many of which are difficult to predict and generally beyond the control of Aperam, that could cause actual results and developments to differ materially and adversely from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in Aperam’s filings with the Luxembourg Stock Market Authority for the Financial Markets (Commission de Surveillance du Secteur Financier). The information is valid only at the time of release and Aperam does not assume any obligation to update or revise its forward-looking statements on the basis of new information, future events, subject to applicable regulation.

 

 

Contact

Investor Relations / Roberta de Aguiar Faria: IR@aperam.com
Communication / Ana Escobedo Conover: communications@aperam.com



Diffusion d’une information Réseau Financier transmis par EQS Group.
Le contenu relève de la responsabilité de l’émetteur.

Voir le contenu original:EQS News


2358254  01-Juil-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière